GENETIC COUNSELING SHARED RESOURCE ABSTRACT The Genetic Counseling (GC) Shared Resource provides cutting-edge genetic services and expertise at an affordable cost to University of Utah (U of U) investigators conducting research related to the inherited basis of cancer. The GC Shared Resource has provided clinical genetics services and supported genetic research at Huntsman Cancer Institute (HCI) since 2003. It was first competed for CCSG support in 2009. Wendy Kohlmann, MS, CGC, a senior genetic counselor, has managed the core since 2006; she oversees a team that includes four additional board-certified genetic counselors and support staff. To achieve its goal of advancing cancer genetics research, the GC Shared Resource provides services including: identifying and recruiting appropriate participants and controls for genetic studies, aiding in study design, addressing ethical and psychosocial issues associated with genetic research, collecting and interpreting family histories, stratifying risk, developing and implementing tailored genetic counseling interventions, and interpreting data. The GC team works individually with investigators to inform them about the services, expertise, infrastructure, data, and biospecimens available through the GC Shared Resource for genetic research and to determine the feasibility and appropriate design of potential studies. The Resource supports funded research through the course of the project, from study design to publication stages. Individuals and families with hereditary cancer susceptibilities are rare, and identifying and recruiting participants for genetic research has the potential to be cost prohibitive. The GC Shared Resource adds important value to the Cancer Center by identifying and maintaining cohorts of individuals and families with various cancer risk profiles so samples and data are readily available for investigators. The GC Shared Resource has also expanded research opportunities by providing infrastructure to return genetic findings back to participants. The GC Shared Resource contributes to a robust translational research program in which genetic discoveries lead to subsequent behavioral and clinical studies, thereby contributing to cancer genetic research at the U of U, as well as cancer prevention and personalized cancer treatment at HCI. The GC Shared Resource is a Cancer Center-managed facility with supervision from HCI Directors and a Faculty Advisory Committee. Surveys are used to assess user satisfaction. The Resource is located in HCI and is thus easily accessible to all Cancer Center members and other campus users. In 2013, use of the Resource by Cancer Center members with peer-reviewed funding exceeded 80%, while the CCSG budget request is only 6% ($37,894) of the total proposed budget.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA042014-30
Application #
9689927
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-05-01
Budget End
2020-04-30
Support Year
30
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Tavtigian, Sean V; Greenblatt, Marc S; Harrison, Steven M et al. (2018) Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework. Genet Med 20:1054-1060
Rogers, R Aaron; Fleming, Aaron M; Burrows, Cynthia J (2018) Unusual Isothermal Hysteresis in DNA i-Motif pH Transitions: A Study of the RAD17 Promoter Sequence. Biophys J 114:1804-1815
Rogers, R Aaron; Fleming, Aaron M; Burrows, Cynthia J (2018) Rapid Screen of Potential i-Motif Forming Sequences in DNA Repair Gene Promoters. ACS Omega 3:9630-9635
Wei, Xiaomu; Calvo-Vidal, M Nieves; Chen, Siwei et al. (2018) Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myeloma. Cancer Res 78:2747-2759
Sample, Danielle C; Samadder, N Jewel; Pappas, Lisa M et al. (2018) Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients. BMC Gastroenterol 18:115
Barrott, Jared J; Illum, Benjamin E; Jin, Huifeng et al. (2018) Paracrine osteoprotegerin and ?-catenin stabilization support synovial sarcomagenesis in periosteal cells. J Clin Invest 128:207-218
Madsen, Michael J; Knight, Stacey; Sweeney, Carol et al. (2018) Reparameterization of PAM50 Expression Identifies Novel Breast Tumor Dimensions and Leads to Discovery of a Genome-Wide Significant Breast Cancer Locus at 12q15. Cancer Epidemiol Biomarkers Prev 27:644-652
Delker, Don A; Wood, Austin C; Snow, Angela K et al. (2018) Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposis Patients: mRNA Signatures of Duodenal Neoplasia. Cancer Prev Res (Phila) 11:4-15
Wu, Yelena P; Parsons, Bridget G; Mooney, Ryan et al. (2018) Barriers and Facilitators to Melanoma Prevention and Control Behaviors Among At-Risk Children. J Community Health 43:993-1001
Trott, Daniel W; Henson, Grant D; Ho, Mi H T et al. (2018) Age-related arterial immune cell infiltration in mice is attenuated by caloric restriction or voluntary exercise. Exp Gerontol 109:99-107

Showing the most recent 10 out of 1193 publications